We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Supports Noninvasive Continuous Dyspnea Monitoring in Ventilated Patients

By HospiMedica International staff writers
Posted on 21 Jul 2026

Shortness of breath, or dyspnea, is a common yet difficult-to-detect symptom in acute and critical care. More...

Clinicians often rely on oxygen saturation to gauge respiratory status, but normal readings can mask severe distress. Missed recognition can worsen the experience of patients on mechanical ventilation and may contribute to longer-term morbidity. Researchers have now identified carbon dioxide as the dominant driver of breathlessness and outlined a noninvasive, machine-learning approach to continuously monitor dyspnea.

Researchers at the University of California, Riverside conducted controlled laboratory experiments with nearly 70 healthy participants, inducing dyspnea by adjusting oxygen and carbon dioxide levels. The work showed that carbon dioxide is the principal stimulus for the sensation of breathlessness, while oxygen levels correlate poorly with perceived respiratory discomfort. The study underscores that outward appearance can be misleading, as individuals who look calm may still report intense distress.

The findings challenge routine dependence on oxygen saturation (SpO2) alone to detect respiratory discomfort. They reinforce evidence around “silent hypoxemia,” in which patients have dangerously low oxygen levels without dyspnea, or feel severe breathlessness despite normal readings. For mechanically ventilated patients, low tidal volumes used to prevent lung injury can intensify the sensation of suffocation, particularly when patients are sedated or unable to communicate.

The research team is developing a predictive tool that uses a machine-learning algorithm to detect dyspnea from noninvasive biomarkers. The goal is continuous monitoring that complements existing measures and supports timely, patient-centered interventions. The study appears in Respiratory Physiology & Neurobiology and highlights the need for better education on dyspnea, which remains underrecognized compared to pain, as well as its clinical relevance in chronic conditions such as chronic obstructive pulmonary disease.

“This challenges a common clinical practice. Clinicians often rely on oxygen saturation in the blood (SpO2) to assess patients. But oxygen levels are often a poor predictor of how breathless someone feels. Carbon dioxide is a much more important driver of this sensation,” said Erica Heinrich, an assistant professor of biomedical sciences in the UCR School of Medicine.

“We need to take dyspnea as seriously as pain. That means better training, better monitoring, and rethinking how we balance lung protection with patient comfort. At its core, the message is simple but urgent: Dyspnea matters,” said Heinrich.

Related Links
UCR School of Medicine


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.